David Simpson
Directeur Général chez Cora Therapeutics, Inc.
Profil
David Simpson is currently the Chief Executive Officer at Cora Therapeutics, Inc. Prior to this, he worked as a Marketing Director at Medtronic Spine LLC, a Principal at Wright Medical Technology, Inc., and a Vice President-Marketing at DFINE, Inc. He obtained his undergraduate degree from The University of Waterloo.
Postes actifs de David Simpson
| Sociétés | Poste | Début |
|---|---|---|
Cora Therapeutics, Inc.
 Cora Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cora Therapeutics, Inc. is a data-driven health solutions company based in Toronto, CA. The product is clinically proven and patented to minimize the irreversible damage to DNA caused by radiation from medical imaging such as CT and X-ray, and cosmic radiation on planes at high altitudes. The Canadian company, under the leadership of Dr. Kieran Murphy, a renowned interventional neuroradiologist, is committed to minimizing the collateral damage caused by radiation exposure. The team is complemented by the esteemed scientific advisor, Dr. Mark Tarnopolsky, who is a frontrunner in evaluating and developing nutraceutical treatments for disorders associated with oxidative stress. The company's first product, Halo antioxidant, is launching in 2022. The company's formulations are developed using the wealth of knowledge possessed by their team and validated through clinical research. The company was founded by Kieran Murphy, and the CEO is David Simpson. | Directeur Général | - |
Anciens postes connus de David Simpson
| Sociétés | Poste | Fin |
|---|---|---|
Medtronic Spine LLC
 Medtronic Spine LLC Medical SpecialtiesHealth Technology Medtronic Spine LLC develops medical devices for invasive therapies. It designs, manufactures and markets instruments used in therapies for the restoration of spinal anatomy. The company was founded in 1994 and is headquartered in Minneapolis, MN. | Sales & Marketing | - |
Wright Medical Technology, Inc.
 Wright Medical Technology, Inc. Medical SpecialtiesHealth Technology Part of Stryker Corp., Wright Medical Technology, Inc. manufactures orthopedic, prosthetic, and surgical appliances and supplies. The company is based in Arlington, TN. | Corporate Officer/Principal | - |
DFINE, Inc.
 DFINE, Inc. Medical SpecialtiesHealth Technology DFINE, Inc.engages in the development and commercialization of medical device system for treating vertebral compression fractures. The company was founded by John H. Shadduck and Csaba Truckai in 2004 and is headquartered in South Jordan, UT. | Sales & Marketing | - |
Formation de David Simpson
| The University of Waterloo | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
DFINE, Inc.
DFINE, Inc. Medical SpecialtiesHealth Technology DFINE, Inc.engages in the development and commercialization of medical device system for treating vertebral compression fractures. The company was founded by John H. Shadduck and Csaba Truckai in 2004 and is headquartered in South Jordan, UT. | Health Technology |
Medtronic Spine LLC
Medtronic Spine LLC Medical SpecialtiesHealth Technology Medtronic Spine LLC develops medical devices for invasive therapies. It designs, manufactures and markets instruments used in therapies for the restoration of spinal anatomy. The company was founded in 1994 and is headquartered in Minneapolis, MN. | Health Technology |
Wright Medical Technology, Inc.
Wright Medical Technology, Inc. Medical SpecialtiesHealth Technology Part of Stryker Corp., Wright Medical Technology, Inc. manufactures orthopedic, prosthetic, and surgical appliances and supplies. The company is based in Arlington, TN. | Health Technology |
Cora Therapeutics, Inc.
Cora Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cora Therapeutics, Inc. is a data-driven health solutions company based in Toronto, CA. The product is clinically proven and patented to minimize the irreversible damage to DNA caused by radiation from medical imaging such as CT and X-ray, and cosmic radiation on planes at high altitudes. The Canadian company, under the leadership of Dr. Kieran Murphy, a renowned interventional neuroradiologist, is committed to minimizing the collateral damage caused by radiation exposure. The team is complemented by the esteemed scientific advisor, Dr. Mark Tarnopolsky, who is a frontrunner in evaluating and developing nutraceutical treatments for disorders associated with oxidative stress. The company's first product, Halo antioxidant, is launching in 2022. The company's formulations are developed using the wealth of knowledge possessed by their team and validated through clinical research. The company was founded by Kieran Murphy, and the CEO is David Simpson. | Commercial Services |
